Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Allergan Inc. v. Barr Laboratories Inc.
Case Number:
1:09-cv-00333
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 28, 2013
Fed. Circ. Upholds Allergan Win Over Lumigan Patent
The Federal Circuit on Monday ruled in favor of specialty pharmaceutical company Allergan Inc., affirming a district court's ruling that two generic-drug makers would infringe on Allergan's patent if they continued plans to manufacture a generic version of glaucoma drug Lumigan.
-
September 08, 2011
Teva, Sandoz Infringed Allergan's Lumigan Patents: Judge
A Delaware federal judge ruled Thursday that a Teva Pharmaceuticals USA Inc. unit and Sandoz Inc. had infringed two of Allergan Inc.'s patents in trying to create a generic version of the glaucoma treatment Lumigan.